Neuregulin-4 (Nrg4), an adipokine, has been shown to ameliorate autophagy dysfunction in T1DM cardiomyopathy by activating AMPK phosphorylation, thus enhancing autophagosome formation. Here, NRG4 is linked to type 1 diabetes mellitus.